157
Participants
Start Date
August 12, 2014
Primary Completion Date
April 24, 2017
Study Completion Date
April 24, 2017
etanercept
etanercept 1 x 50 mg/week or 2 x 25mg/week
etanercept
etanercept 1 x 50 mg/week or 2 x 25mg/week
Centre Hospitalier Universitarie Brugmann, Brussels
CHIREC, Brussels
Louisastraat 18, Mechelen
Biomedical Research Institute/ Department of Rheumatology, Genk
Private Practice Rheumatology, Genk
ReumaClinic, Genk
Reumatologie Associatie, Genk
Centre Hospitalier Universitaire Sart Tilman, Department of Rheumatology, Liège
CHU Sart Tilman/ Department of Rheumatology, Liège
Private Practice, Grand-Manil
CHU Dinant Godinne, Yvoir
Avenue G Therasse 1, Yvoir
Cliniques Universitaires UCL de Mont-Godinne, Yvoir
Hôpital Saintethérèse, Montigny Sur Sambre
ISPPC de Charleroi, Montigny-le-Tilleul
CHU Tivoli, La Louvière
St. Lucas ZH, Assebroeck
AZ Damiaan, Ostend
Universitair Ziekenhuis Gent, Ghent
AZ Sint Blasius, Dendermonde
ASZ Aalst, Aalst
AZ Alma, Eeklo
Algemeen Stedelijk Ziekenhuis, Aalst
Onze Lieve Vrouw Ziekenhuis Aalst, Aalst
Onze Lieve Vrouw Ziekenhuis, Aalst
St-Lucas Ziekenhuis, Assebroek
Private Practice, Champion
Private Practice, Genk
GHdC, Gilly
AZ Groeninge Campus Sint Maarten, Kortrijk
CHU, Liège
CHU Ambroise Pare, Mons
Office of Maenaut Kristien, Schoten
Sint-Andries Ziekenhuis, Tielt
CH Peltzer-Tourelle, Verviers
Lead Sponsor
Pfizer
INDUSTRY